NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. DESCRIPTION OF BUSINESS
MACOM Technology Solutions Holdings, Inc. (the “Company”) was incorporated in Delaware on March 25, 2009. We design, develop and manufacture differentiated semiconductor products and solutions for the I&D, Data Center and Telecom industries for customers who demand high performance, quality and reliability. We are headquartered in Lowell, Massachusetts, with operational facilities throughout North America, Europe and Asia. Refer to Item 1 - Business, for additional information.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Principles of Consolidation and Basis of Presentation—We have one reportable operating segment that designs, develops, manufactures and markets semiconductors and modules. The accompanying consolidated financial statements include our accounts and the accounts of our majority-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. In the consolidated financial statements, certain prior year balances in Note 11 - Accrued Liabilities have been reclassified to conform to the current year presentation.
We have a 52- or 53-week fiscal year ending on the Friday closest to the last day of September. Fiscal years 2026 and 2024 included 52 weeks, and fiscal year 2025 included 53 weeks. To offset the effect of holidays, for fiscal years in which there are 53 weeks, we typically include the extra week arising in our fiscal years in the first quarter. Our first quarter of fiscal year 2025, ended January 3, 2025, included 14 weeks.
Use of Estimates—The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities during the reporting periods, the reported amounts of revenue and expenses during the reporting periods and the disclosure of contingent assets and liabilities at the date of the financial statements. On an ongoing basis, we base estimates and assumptions on historical experience, currently available information and various other factors that management believes to be reasonable under the circumstances. Actual results may differ materially from these estimates and assumptions. The accounting policies which our management believes involve the most significant application of judgment or involve complex estimation, are inventories and associated reserves; revenue reserves; business combinations; goodwill and intangible asset valuation; share-based compensation valuation and income taxes.
Foreign Currency Translation and Remeasurement—Our consolidated financial statements are presented in U.S. dollars. While the majority of our foreign operations use the U.S. dollar as the functional currency, the financial statements of our foreign operations for which the functional currency is not the U.S. dollar are translated into U.S. dollars at the exchange rates in effect at the balance sheet dates (for assets and liabilities), historical rates for equity and at average exchange rates (for revenue and expenses). The unrealized translation gains and losses on the net investment in these foreign operations are accumulated as a component of other comprehensive (loss) income.
The financial statements of our foreign operations where the functional currency is the U.S. dollar, but where the underlying transactions are transacted in a different currency, are remeasured at the exchange rate in effect at the balance sheet date with respect to monetary assets and liabilities. Nonmonetary assets and liabilities, such as inventories and property and equipment and related statements of operations accounts, such as cost of revenue and depreciation, are remeasured at historical exchange rates. Revenue and expenses, other than cost of revenue, amortization and depreciation, are translated at the average exchange rate for the period in which the transaction occurred. The net gains and losses on foreign currency remeasurement are reflected in selling, general and administrative expense in the accompanying Consolidated Statements of Operations. Net foreign exchange transaction gains and losses for all periods presented were not material.
Cash and Cash Equivalents—Cash equivalents are primarily composed of short-term, highly-liquid instruments with an original maturity of 90 days or less and consist primarily of money market funds.
Short-term Investments—We classify our short-term investments as available-for-sale. Our investments classified as available-for-sale are recorded at fair value at period end. We classify available-for-sale investments with maturity dates greater than twelve months as short-term investments rather than long-term investments based on the nature of the securities and the availability for use in current operations. We believe this method is more reflective of our assessment of our overall liquidity position. Unrealized gains and losses that are deemed to be unrelated to credit losses are recorded in accumulated other comprehensive (loss) income as a separate component of stockholders’ equity.
A decline in the fair value of any debt security below cost that is deemed to be attributable to credit loss results in a charge to earnings and the corresponding establishment of an allowance for credit losses against the cost basis of the security. Premiums and discounts are amortized (accreted) over the life of the related security as an adjustment to its yield. Dividend and interest income are recognized when earned. Realized gains and losses are included in Interest income in our Consolidated Statements of Operations and are derived using the specific identification method for determining the cost of investments sold.
Inventories—Inventories are stated at the lower of cost or net realizable value. We use a combination of standard cost and moving weighted-average cost methodologies to determine the cost basis for our inventories, approximating a first-in, first-out basis. The standard cost of finished goods and work-in-process inventory is composed of material, labor and manufacturing overhead, which approximates actual cost. In addition to stating inventory at the lower of cost or net realizable value, we also evaluate inventory each reporting period for excess quantities and obsolescence, and establish reserves when necessary based upon historical experience, assessment of economic conditions and expected demand. Once recorded, these reserves are considered permanent adjustments to the carrying value of inventory.
Property and Equipment—Property and equipment is stated at cost, less accumulated depreciation and amortization. Expenditures for maintenance and repairs are charged to expense as incurred, whereas major improvements that significantly extend the useful life of the assets are capitalized as additions to property and equipment.
As of September 28, 2024, the Company changed its accounting estimate for the expected useful lives of certain fabrication-related machinery and equipment. The Company evaluated its current asset base and reassessed the estimated useful lives of certain machinery and equipment in connection with its recent usage of older equipment, including considering the technological and physical obsolescence of such machinery and equipment. Based on our ability to re-use equipment across generations of process technologies and historical usage trends, the Company determined that the expected useful lives for certain fabrication-related machinery and equipment should be increased to ten years to reflect more closely the estimated economic lives of those assets. This change in estimate was applied prospectively effective for the first quarter of fiscal year 2025 and resulted in a decrease in depreciation expense within cost of revenue of $2.5 million and decreased net loss per share by $0.04 for the fiscal year ended October 3, 2025.
Property and equipment are depreciated or amortized using the straight-line method over the following estimated useful lives:
| | | | | |
| Asset Classification | Estimated Useful Life (In Years) |
| Buildings and improvements | 20 - 40 |
Computer equipment and software | 2 - 5 |
Furniture and fixtures | 7 - 10 |
| Finance lease assets and leasehold improvements | Shorter of useful life or term of lease |
Machinery and equipment | 2 - 10 |
Business Combinations—Business combinations are accounted for under the acquisition method of accounting. Amounts paid for an acquisition are allocated to the assets acquired and liabilities assumed based on their fair values at the date of acquisition. The accounting for business combinations requires estimates and judgment in determining the fair value of assets acquired and liabilities assumed, regarding expectations of future cash flows of the acquired business, and the allocation of those cash flows to the identifiable intangible assets. The determination of fair value is based on management’s estimates and assumptions, as well as other information compiled by management, including valuations that utilize customary valuation procedures and techniques. If actual results differ from these estimates, the amounts recorded in the financial statements could be impaired.
Acquisition costs are expensed as incurred and recorded in selling, general and administrative expenses.
Goodwill and Indefinite-Lived Intangible Assets—We have goodwill and certain intangible assets with indefinite lives which are not subject to amortization. These are reviewed for impairment annually as of the end of our fiscal August month end and more frequently if events or changes in circumstances indicate that the assets may be impaired. For our assessment of goodwill impairment, we compare the fair value to the carrying value of the reporting unit. For our assessment of indefinite-lived assets we compare the carrying value of the asset to the estimated fair value of the asset. If impairment exists, a loss is recorded to write down the value of the assets to their fair values. We performed our annual impairment tests of our goodwill and indefinite-lived intangible assets and the results of these tests indicated that our goodwill and indefinite-lived intangible assets were not impaired in any of the three fiscal years ended October 2, 2026.
Long-Lived Asset Valuation and Impairment Assessment—Long-lived assets include property and equipment and definite-lived intangible assets subject to amortization. We evaluate long-lived assets for recoverability when events or changes in circumstances indicate that their carrying amounts may not be recoverable. Circumstances which could trigger a review include, but are not limited to, significant decreases in the market price of the asset or asset group, significant adverse changes in the business climate or legal factors, the accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of the asset, current period cash flow or operating losses combined with a history of losses or a forecast of continuing losses associated with the use of the asset and a current expectation that the asset will more likely than not, be sold or disposed of significantly before the end of its previously estimated useful life.
In evaluating a long-lived asset for recoverability, we estimate the undiscounted cash flows expected to result from our use and eventual disposition of the asset. If the sum of the expected undiscounted cash flows is less than the carrying amount of the asset group, an impairment loss, equal to the excess of the carrying amount over the fair value of the asset, is recognized.
Other Intangible Assets—Our other intangible assets, including acquired technology, customer relationships, certain trade names and internal-use software, are definite-lived assets and are subject to amortization. We amortize definite-lived assets over their estimated useful lives, which range from two to fourteen years, generally based on the pattern over which we expect to receive the economic benefit from these assets.
Leases—We have operating leases for certain facilities and to a lesser extent, various manufacturing equipment. We have finance leases for our corporate headquarters. These leases expire at various dates through 2043, and certain of these leases have renewal options with the longest ranging up to two ten-year periods.
We determine that a contract contains a lease at lease inception if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. In evaluating whether the right to control an identified asset exists, we assess whether we have the right to direct the use of the identified asset and obtain substantially all of the economic benefit from the use of the identified asset. Leases with a term greater than one year are recognized on the balance sheet as right-of-use (“ROU”) assets and lease liabilities. For leases with a term of one year or less, categorized as short-term leases, we elected not to recognize the lease liability for these arrangements and the lease payments are recognized in the Consolidated Statements of Operations on a straight-line basis over the lease term. ROU assets and lease liabilities are recognized at the present value of future minimum lease payments over the lease term on the commencement date. ROU assets are initially measured as the amount of the initial lease liability, adjusted for initial direct costs, lease payments made at or before the commencement date, and reduced by lease incentives received. We include options to renew or terminate when determining the lease term when it is reasonably certain that the option will be exercised. Our lease agreements do not contain any material residual value guarantees or restrictive covenants.
Our leases may contain lease and non-lease components. For certain manufacturing equipment leases, we have elected to separate payments for lease components from non-lease components. For all other leases, we have elected to account for lease and non-lease components in a contract as part of a single lease component. Fixed payments are considered part of the single lease component and included in the ROU assets and lease liabilities. Additionally, lease contracts typically include variable payments and other costs that do not transfer a separate good or service, such as reimbursement for real estate taxes and insurance, which are expensed as incurred.
Our leases generally do not provide an implicit interest rate. As a result, we utilize current industry borrowing rates for similar companies with similar ratings.
Revenue Recognition—Our revenue is derived primarily from sales of high-performance RF, microwave, millimeter wave, optical and photonic semiconductor products into three primary markets: I&D, Data Center and Telecom.
We recognize revenue within the scope of ASC 606, Revenue from Contracts with Customers. Revenue is recognized when a customer obtains control of products or services in an amount that reflects the consideration which we expect to receive in exchange for those goods or services. To determine revenue recognition for arrangements within the scope of ASC 606, we perform the following five steps: (1) identify the contract(s) with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) we satisfy performance obligations. Sales, value add and other taxes collected on behalf of third parties are excluded from revenue. Our revenue arrangements do not contain significant financing components.
Contracts with our customers principally contain only one distinct performance obligation, which is the sale of products. However, due to multiple products potentially being sold on a single order, we are required to allocate consideration based on the estimated relative standalone selling prices of the promised products.
Periodically, we enter into non-product development and license contracts with certain customers. We generally recognize revenue from these contracts over-time as services are provided based on the terms of the contract. Non-product development and license revenue is not significant to our Revenue or Consolidated Statements of Operations for the periods presented. Revenue is deferred for amounts billed or received prior to delivery of the services. Certain contracts may contain multiple performance obligations for which we allocate revenue to each performance obligation based on the relative standalone selling price.
Our product revenue is recognized when the customer obtains control of the product, which generally occurs at a point in time, and is based on the contractual shipping terms of a contract. For each contract, the promise to transfer the control of the products or services, each of which is individually distinct, is considered to be the identified performance obligation. We provide an assurance type warranty which is not sold separately and does not represent a separate performance obligation. Therefore, we account for such warranties under ASC 460, Guarantees, and the estimated costs of warranty claims are generally accrued as cost of revenue in the period the related revenue is recorded.
We have agreements with certain distribution customers which may include certain rights of return and pricing programs, including returns for aged inventory, stock rotation and price protection which affect the transaction price. Sales to these customers and programs offered are in accordance with terms set forth in written agreements, which require us to assess the potential revenue effects of this variable consideration utilizing the expected value method. Variable consideration is included in the transaction price if, in our judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. As such, revenue on sales to customers that include rights of return and pricing programs are recorded net of estimated variable consideration,
utilizing the expected value method based on historical sales data. We believe that the judgments and estimates we utilize are reasonable based upon current facts and circumstances, however utilizing different judgments and estimates could result in different amounts.
Practical Expedients and Elections—ASC 606 requires that we disclose the aggregate amount of transaction price that is allocated to performance obligations that have not yet been satisfied as of the reporting periods presented. The guidance provides certain practical expedients that limit this requirement and, therefore, we do not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which revenue is recognized at the amount to which we have the right to invoice for services performed. We have elected not to disclose the aggregate amount of transaction prices associated with unsatisfied or partially unsatisfied performance obligations for contracts where these criteria are met.
Our policy is to capitalize any incremental costs incurred to obtain a customer contract, only to the extent that the benefit associated with the costs is expected to be longer than one year. Capitalizable contract costs were not significant as of October 2, 2026 and October 3, 2025.
We account for shipping and handling activities related to contracts with customers as costs to fulfill the promise to transfer the associated products. When shipping and handling costs are incurred after a customer obtains control of the products, we have elected to account for these as costs to fulfill the promise and not as a separate performance obligation. Shipping and handling costs associated with the distribution of products to customers are recorded in costs of revenue generally when the related product is shipped to the customer.
Research and Development Costs—Costs incurred in the research and development of products are expensed as incurred.
Income Taxes—Deferred tax assets and liabilities are recognized based on temporary differences between the financial reporting and income tax bases of assets and liabilities, using rates anticipated to be in effect when such temporary differences reverse. A valuation allowance against net deferred tax assets is required if, based upon the available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. On a periodic basis, we reassess the valuation allowance on our deferred income tax assets weighing positive and negative evidence, including both historical and prospective information, with greater weight given to evidence that is objectively verifiable, to assess the recoverability of our deferred tax assets. The periodic assessments include, among other things, our recent financial performance and our future projections.
We provide reserves for potential payments of tax to various tax authorities related to uncertain tax positions and other issues. Reserves are based on a determination of whether and how much of a tax benefit is taken by us in our tax filings or positions that are more likely than not to be realized following an examination by taxing authorities. We recognize the financial statement benefit of an uncertain tax position only after considering the probability that a tax authority would sustain the position in an examination. For tax positions meeting a “more-likely-than-not” threshold, the amount recognized in the financial statements is the benefit expected to be realized upon settlement with the tax authority. For tax positions not meeting the threshold, no financial statement benefit is recognized. Potential interest and penalties associated with such uncertain tax positions are recorded as a component of income tax expense.
Earnings Per Share—Basic net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding during the period, excluding the dilutive effect of common stock equivalents. Diluted net income (loss) per share reflects the dilutive effect of common stock equivalents, such as stock options, restricted stock units using the treasury stock method and convertible debt using the if-converted method.
Fair Value Measurements—Financial assets and liabilities are measured at fair value. Fair value is an exit price, representing the amount that would be received from the sale of an asset or paid to transfer a liability at the measurement date under current market conditions in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, we group financial assets and liabilities in a three-tier fair value hierarchy, according to the inputs used in measuring fair value as follows:
•Level 1—observable inputs such as quoted prices in active markets for identical assets and liabilities;
•Level 2—inputs other than quoted prices in active markets that are observable either directly or indirectly, such as quoted prices in active markets for similar assets and liabilities, quoted prices for identical assets and liabilities in markets that are not active and model-based valuation techniques for which significant assumptions are observable in active markets; and,
•Level 3—unobservable inputs for which there is little or no market data, requiring us to develop our own assumptions for model-based valuation techniques.
This hierarchy requires us to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. We recognize transfers between levels of the fair value hierarchy at the end of the reporting period.
Money market funds are actively traded and consist of highly liquid investments with original maturities of 90 days or less. They are measured at their fair value and classified as Level 1. U.S. Treasury securities consist of U.S. Treasury Notes and U.S. Treasury T-
Bills that mature in less than 1 year and are classified as Level 1. Corporate and agency bonds and commercial paper are categorized as Level 2 assets except where sufficient quoted prices exist in active markets, in which case such securities are categorized as Level 1 assets. These securities are valued using third-party pricing services. These services may use, for example, model-based pricing methods that utilize observable market data as inputs. We generally use quoted prices for recent trading activity of assets with similar characteristics to the debt security or bond being valued. The securities and bonds priced using such methods are generally classified as Level 2. Broker dealer bids or quotes on securities with similar characteristics may also be used.
For forward foreign currency contracts, the significant inputs are over-the-counter quoted market prices for similar instruments and exchange rate curves of the foreign currency for translating future cash flows. These derivatives are classified as Level 2 as the fair value determination was based on observable inputs.
Marketable equity securities are actively traded and consist of the Equity Investment in Investee (as defined in Note 5 - Investments). They are measured at their fair value and classified as Level 1. Non-marketable debt securities consist of the Debt Investment in Investee (as defined in Note 5 - Investments) and are categorized as Level 2. These securities do not have readily determinable market values and are estimated using observable inputs.
The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate fair value due to the short-term nature of these assets and liabilities.
Share-Based Compensation—We account for all share-based compensation arrangements using the fair value method. We recognize compensation expense using the straight-line method for service-based awards and the accelerated method for performance-based awards, and providing that the minimum amount of compensation recorded is equal to the vested portion of the award. We record the expense in the Consolidated Statements of Operations in the same manner in which the award recipients’ salary costs are classified. For restricted stock unit awards, we use the closing stock price on the date of grant to estimate the fair value of the awards. For restricted stock units with both service and performance conditions, this grant-date fair value is also impacted by the number of units that are expected to vest during the performance period and is adjusted through the related stock-based compensation expense at each reporting period based on the probability of achievement of that performance condition. If we determine that an award is unlikely to vest, any previously recorded stock-based compensation expense is reversed in the period of that determination. We use the Monte Carlo Simulation analysis to estimate the fair value of restricted stock units with market conditions, inclusive of assumptions for risk free interest rates, expected term, expected volatility and the target price. We derive the risk-free interest rate assumption from the U.S. Treasury’s rates for U.S. Treasury zero-coupon bonds with maturities similar to the expected term of the award being valued. We base the assumed dividend yield on our expectation of not paying dividends in the foreseeable future. We calculate the weighted-average expected term of the awards using historical data. In addition, we calculate our estimated volatility using our historical stock price volatility data. We account for forfeitures when they occur.
Share-based awards that are settled in cash are recorded as liabilities. The measurement of the liability and compensation cost for these awards is based on the fair value of the award as of each period end date, which is equivalent to the closing price of a share of our common stock on the period end date multiplied by the number of units earned, and is recorded in operating income over the award’s vesting period. Changes in our payment obligation prior to the settlement date of a stock-based award are recorded as compensation expense in operating income in the period of the change. The final payment amount for such awards is established on the date of vesting.
Guarantees and Indemnification Obligations—We enter into agreements in the ordinary course of business with, among others, customers, distributors and OEMs. Most of these agreements require us to indemnify the other party against third-party claims alleging that a Company product infringes a patent and/or copyright. Certain agreements in which we grant limited licenses to Company intellectual property require us to indemnify the other party against third-party claims alleging that the use of the licensed intellectual property infringes a third-party's intellectual property. Certain of these agreements require us to indemnify the other party against certain claims relating to property damage, personal injury or the acts or omissions of the Company, its employees, agents or representatives. In addition, from time to time, we have made certain guarantees in the form of warranties regarding the performance of Company products to customers.
We have agreements with certain vendors, creditors, lessors and service providers pursuant to which we have agreed to indemnify the other party for specified matters, such as acts and omissions of the Company, its employees, agents or representatives.
We have procurement or license agreements with respect to technology used in our products and agreements in which we obtain rights to a product from an OEM. Under some of these agreements, we have agreed to indemnify the supplier for certain claims that may be brought against such party with respect to our acts or omissions relating to the supplied products or technologies.
Our certificate of incorporation and agreements with certain of our directors and officers and certain of our subsidiaries’ directors and officers provide them indemnification rights, to the extent legally permissible, against liabilities incurred by them in connection with legal actions in which they may become involved by reason of their service as a director or officer. As a matter of practice, we maintain director and officer liability insurance coverage, including coverage for directors and officers of acquired companies.
We have not experienced any losses related to these indemnification obligations in any period presented and no claims with respect thereto were outstanding as of October 2, 2026 and October 3, 2025. We do not expect significant claims related to these indemnification obligations and, consequently, have concluded that the fair value of these obligations is negligible. No liabilities related to indemnification liabilities have been established.
Recent Accounting Pronouncements
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280) Improvements to Reportable Segment Disclosures, which improves disclosures about a public entity’s reportable segments and addresses requests from investors and other allocators of capital for additional, more detailed information about a reportable segment’s expenses. The amendments in this update improve financial reporting by requiring disclosure of incremental segment information on an annual and interim basis for all public entities to enable investors to develop more decision-useful financial analyses. This ASU should be applied on a retrospective basis. We adopted the annual disclosure requirements in fiscal year 2025 and the interim disclosure requirements beginning in the first quarter of fiscal year 2026. See Note 25 - Segment Reporting, Geographic and Significant Customer Information for additional information.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740) Improvements to Income Tax Disclosures, which require greater disaggregation of income tax disclosures. The amendments in this update improve the transparency of income tax disclosures by requiring (1) consistent categories and greater disaggregation of information in the rate reconciliation and (2) income taxes paid disaggregated by jurisdiction. Other amendments in this update improve the effectiveness and comparability of disclosures by (1) adding disclosures of pretax income (or loss) and income tax expense (or benefit) and (2) removing disclosures that no longer are considered cost beneficial or relevant. This ASU should be applied on a prospective basis, with retrospective application permitted. We adopted this ASU on a prospective basis for the fiscal year ended October 2, 2026 for annual reporting periods. See Note 20 - Income Taxes for additional information.
In September 2025, the FASB issued ASU 2025-06, Intangible - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. The ASU requires entities to begin capitalizing software costs when management authorizes and commits to funding the software project, and it is probable that the project will be completed and the software will be used for its intended purpose. We elected to early adopt ASU 2025-06 in the second quarter of fiscal year 2026 and the adoption of this update did not have a material impact on our consolidated financial statements and related disclosures.
Pronouncements for Adoption in Subsequent Periods
In November 2024, the FASB issued ASU 2024-03, Income Statement Reporting Comprehensive Income - Expense Disaggregation Disclosures, as amended by ASU 2025-01, Income Statement Reporting Comprehensive Income - Expense Disaggregation Disclosures: Clarifying the Effective Date, which requires disclosure, in the notes to financial statements, of specified information about certain costs and expenses. The amendments in this update improve financial reporting by requiring that public business entities disclose additional information about specific expense categories in the notes to financial statements at interim and annual reporting periods. This ASU should be applied on a prospective basis, with retrospective application permitted. The amendments in this update are effective for annual reporting periods beginning after December 15, 2026 and interim periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted. We are currently evaluating the future effect the adoption of this ASU will have on our consolidated financial statements and related disclosures.
In July 2025, the FASB issued ASU 2025-05, Financial Instruments - Credit Losses (Topic 326) Measurement of Credit Losses for Accounts Receivable and Contract Assets. The ASU amends guidance for measuring credit losses on current accounts receivable and contract assets that arise from transactions accounted for under ASC 606, Revenue from Contracts with Customers, by providing all entities with the ability to elect a practical expedient that assumes that current conditions as of the balance sheet date do not change for the remaining life of the asset. This ASU should be applied on a prospective basis. The guidance in this update is effective for annual reporting periods beginning after December 15, 2025 and interim reporting periods within those annual reporting periods, with early adoption permitted. Adoption of this ASU is not expected to have a material impact on our consolidated financial statements and related disclosures.
3. REVENUE
Disaggregation of Revenue
We disaggregate revenue from contracts with customers by markets and geography, as we believe it best depicts how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.
The following tables present our revenue disaggregated by markets and geography (in thousands):
| | | | | | | | | | | | | | | | | |
| Fiscal Years |
| 2026 | | 2025 | | 2024 |
| Industrial & Defense | $ | 536,367 | | | $ | 419,785 | | | $ | 351,639 | |
| Data Center | 509,672 | | | 292,836 | | | 197,875 | |
| Telecom | 281,584 | | | 254,637 | | | 180,064 | |
| Total | $ | 1,327,623 | | | $ | 967,258 | | | $ | 729,578 | |
| | | | | | | | | | | | | | | | | |
| Fiscal Years |
| Revenue by Geographic Region | 2026 | | 2025 | | 2024 |
| United States | $ | 505,795 | | | $ | 422,857 | | | $ | 327,682 | |
| China | 501,028 | | | 274,627 | | | 177,696 | |
| Asia Pacific, excluding China (1) | 154,452 | | | 111,498 | | | 89,294 | |
| Other Countries (2) | 166,348 | | | 158,276 | | | 134,906 | |
| Total | $ | 1,327,623 | | | $ | 967,258 | | | $ | 729,578 | |
(1)Asia Pacific primarily represents Japan, Singapore, South Korea and Taiwan.
(2)No country or region represented greater than 10% of our total revenue for the periods presented, other than the United States, China and the Asia Pacific region as presented above.
Revenue by geographic region is aggregated by customer billing address.
Contract Balances
We record contract assets or contract liabilities depending on the timing of revenue recognition, billings and cash collections on a contract-by-contract basis. Our contract liabilities primarily relate to deferred revenue, including advanced consideration received from customers for contracts prior to the transfer of control to the customer, and therefore revenue is subsequently recognized upon delivery of products and services.
As of October 2, 2026, October 3, 2025 and September 27, 2024 our contract liabilities were $1.4 million, $7.7 million and $5.3 million, respectively. During the fiscal years ended October 2, 2026, October 3, 2025 and September 27, 2024, we recognized net sales of $6.7 million, $2.3 million and $2.5 million, respectively, that were included in the contract liabilities balance at the beginning of the period. The decrease in contract liabilities during the fiscal year ended October 2, 2026 was primarily related to recognition of revenue that was previously deferred for products and services invoiced prior to when certain of our customers obtained control of such products and/or services, partially offset by deferral of revenue for additional invoicing prior to when our customers obtain control of such products and/or services.
4. ACQUISITIONS
ENGIN-IC, Inc.—On November 5, 2024, we completed the acquisition of ENGIN-IC, Inc. (“ENGIN-IC”), a fabless semiconductor company that designs advanced gallium arsenide (“GaAs”) and gallium nitride (“GaN”) monolithic microwave integrated circuits (“MMICs”) and integrated microwave assemblies located in Plano, Texas and San Diego, California (the “ENGIN-IC Acquisition”). We acquired ENGIN-IC to further expand and strengthen our MMIC and module design capabilities. In connection with the ENGIN-IC Acquisition, we acquired all of the outstanding shares of ENGIN-IC for a total purchase price of approximately $14.4 million with cash consideration of $12.7 million, net of cash acquired of $0.2 million, and deferred consideration payable of $1.5 million related to customary agreement provisions not associated with future performance of the acquired business, which was paid during the fiscal year ended October 2, 2026. The ENGIN-IC Acquisition was accounted for as a business combination and the operations of ENGIN-IC have been included in our consolidated financial statements since the date of acquisition. We finalized the ENGIN-IC Acquisition purchase accounting during the fiscal quarter ended January 2, 2026 and adjustments were immaterial. We recorded the final allocation of the purchase price for ENGIN-IC, which primarily resulted in intangible assets, including acquired technology and customer relationships, of $9.7 million and goodwill of $5.1 million.
Consolidated estimated pro forma unaudited revenue and consolidated estimated pro forma net income (loss) during the fiscal years ended October 3, 2025 and September 27, 2024 and the actual results of operations for ENGIN-IC since the acquisition date are not material to our consolidated financial statements.
RF Business of Wolfspeed, Inc.—On December 2, 2023, we completed the acquisition of certain assets and specified liabilities of the radio frequency (“RF”) business (the “RF Business”) of Wolfspeed, Inc. (the “Seller”), which was accounted for as a business combination (the “RF Business Acquisition”). The RF Business includes a portfolio of GaN on Silicon Carbide products used in high-performance RF and microwave applications. In connection with the RF Business Acquisition, we assumed control of a wafer fabrication facility in RTP, North Carolina (the “RTP Fab”) on July 25, 2025 (the “RTP Fab Transfer”). Prior to the RTP Fab Transfer, the Seller continued to operate the facility and supply wafer product and other fabrication services to us pursuant to various agreements entered into between the parties concurrently with the closing of the RF Business Acquisition.
The purchase price for the RF Business Acquisition consisted of $75.0 million payable in cash, subject to customary purchase price adjustments, and 711,528 shares of our common stock, with a fair value of $57.7 million, which were issued at the closing of the RF Business Acquisition. The shares of our common stock issued in connection with the RF Business Acquisition were subject to restrictions on the sale of shares until completion of the RTP Fab Transfer. In addition, if the RTP Fab had not transferred by the fourth anniversary of the closing date of the RF Business Acquisition, the Seller would have forfeited 25.0% of the share consideration. We funded the cash purchase price for the RF Business Acquisition through cash-on-hand.
During the fiscal years ended October 2, 2026 and October 3, 2025, we did not incur any acquisition-related transaction costs. During the fiscal year ended September 27, 2024, we incurred acquisition-related transaction costs of approximately $7.4 million, which are included in selling, general and administrative expense in our Consolidated Statements of Operations.
We finalized the RF Business Acquisition purchase accounting during the fiscal quarter ended January 3, 2025. The following table summarizes the final purchase price (in thousands, except shares and closing share price amount):
| | | | | | | | | | | | | | |
| | | | | | | | At Acquisition Date as Reported January 3, 2025 |
| | | | |
| Cash purchase consideration | | | | | | | | $ | 72,802 | |
| Number of shares of MACOM common stock issued at closing | | | | | 711,528 | | | | |
| Fair value of shares issued | | | | | $ | 81.14 | | | | |
| Equity purchase consideration | | | | | | | | 57,733 | |
| | | | | | | | |
| Total purchase consideration | | | | | | | | $ | 130,535 | |
The final purchase price has been allocated as follows (in thousands):
| | | | | | | | | | | |
| At Acquisition Date as Reported September 27, 2024 | Measurement Period Adjustments | At Acquisition Date as Reported January 3, 2025 |
|
| Current assets | $ | 39 | | $ | — | | $ | 39 | |
| Inventory | 31,097 | | 649 | | 31,746 | |
| Property and equipment | 35,415 | | — | | 35,415 | |
| Intangible assets | 42,000 | | 1,800 | | 43,800 | |
| Prepayment for net assets associated with the RTP Fab Transfer | 16,250 | | — | | 16,250 | |
| Other non-current assets | 5,837 | | — | | 5,837 | |
| Goodwill | 9,967 | | (859) | | 9,108 | |
| Total assets acquired | 140,605 | | 1,590 | | 142,195 | |
| Current liabilities | 6,882 | | 1,590 | | 8,472 | |
| Long-term liabilities | 3,188 | | — | | 3,188 | |
| Total liabilities assumed | 10,070 | | 1,590 | | 11,660 | |
| Purchase Price | $ | 130,535 | | $ | — | | $ | 130,535 | |
Intangible assets consist of technology, a favorable contract and customer relationships with fair values of $21.0 million, $14.5 million and $8.3 million, respectively, and useful lives of 4.8 years, 2.0 years and 8.8 years, respectively. We used variations of income approaches with estimates and assumptions developed by us to determine the fair values of technology, the favorable contract and customer relationships. We valued technology by using the relief-from-royalty method, the favorable contract by using the discounted cash flow method and customer relationships by using the multi-period excess earnings method. We valued backlog using the multi-period excess earnings method and determined that the value for backlog is zero. The process for estimating the fair values of identifiable intangible assets requires the use of significant estimates and assumptions, including revenue growth rates, royalty rates, operating margin and discount rates. We used the cost and market approaches to determine the fair value of our property and equipment. We amortize definite-lived assets based on the pattern over which we expect to receive the economic benefit from these assets.
On July 25, 2025, we completed the RTP Fab Transfer. At the time of purchase accounting, $16.3 million of the purchase price was estimated as a prepayment associated with the fair value of property and equipment, inventory and liabilities to be acquired with the RTP Fab Transfer. This amount was comprised of $10.4 million for property and equipment, $6.4 million for inventory and $0.5 million for an employee benefits accrual. Property and equipment, inventory and the employee benefits accrual acquired on July 25, 2025 were valued at $10.1 million, $16.7 million, and $0.5 million, respectively, for a total value of $26.3 million. The revised inventory valuation reflects new information obtained outside of the measurement period which ended in December 2024. As a result, we recorded a net gain of $10.1 million to Other income during the fiscal fourth quarter ended October 3, 2025. The gain on inventory resulted from receiving a greater quantity of raw materials and work-in-process inventory than originally estimated at the end of the measurement period in December 2024.
The RF Business has been included in our consolidated financial statements since the date of acquisition. During the fiscal year ended September 27, 2024, the RF Business contributed $138.7 million of our total revenue. During the fiscal year ended September 27, 2024, the RF Business did not materially impact our consolidated net income.
Consolidated estimated pro forma unaudited revenue and net income as if the RF Business Acquisition had occurred on October 1, 2022, is as follows (in thousands):
| | | | | | | | |
| Fiscal Year | |
| 2024 | | | |
| Consolidated estimated pro forma unaudited revenue | $ | 756,415 | | | | |
| Consolidated estimated pro forma unaudited net income | $ | 55,991 | | | | |
Pro forma revenue and net income was prepared for comparative purposes only and is not indicative of what would have occurred had the acquisition actually occurred on October 1, 2022, or of the results that may occur in the future. Pro forma net income includes business combination accounting effects from the RF Business Acquisition, primarily amortization expense from acquired intangible assets, acquisition transaction costs and tax-related effects. Pro forma earnings for the fiscal year ended September 27, 2024 were adjusted to exclude transaction costs incurred of $15.8 million.
5. INVESTMENTS
Short-Term Investments
All short-term investments are invested in corporate bonds, commercial paper, U.S. Treasury securities and agency bonds, and are classified as available-for-sale. The amortized cost, gross unrealized holding gains or losses and fair value of our available-for-sale investments by major investments type are summarized in the tables below (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| October 2, 2026 |
| Amortized Cost | Gross Unrealized Holding Gains | Gross Unrealized Holding Losses | Aggregate Fair Value |
| | | | | | | | |
| Corporate bonds | | $ | 639,744 | | | $ | 24 | | | $ | (6,271) | | | $ | 633,497 | |
| | | | | | | | |
| U.S. Treasuries and agency bonds | | 47,414 | | | 3 | | | (518) | | | 46,899 | |
| | | | | | | | |
| Total investments | | $ | 687,158 | | | $ | 27 | | | $ | (6,789) | | | $ | 680,396 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| October 3, 2025 |
| Amortized Cost | Gross Unrealized Holding Gains | Gross Unrealized Holding Losses | Aggregate Fair Value |
| | | | | | | | |
| | | | | | | | |
| Corporate bonds | | 554,433 | | | 3,222 | | | (76) | | | 557,579 | |
| Commercial paper | | 49,510 | | | 6 | | | — | | | 49,516 | |
| U.S. Treasuries and agency bonds | | 66,594 | | | 155 | | | (11) | | | 66,738 | |
| Total investments | | $ | 670,537 | | | $ | 3,383 | | | $ | (87) | | | $ | 673,833 | |
The contractual maturities of available-for-sale investments were as follows (in thousands):
| | | | | | | | |
| October 2, 2026 | | |
| Less than 1 year | $ | 164,970 | | | | |
| Over 1 year | 515,426 | | | | |
| Total investments | $ | 680,396 | | | | |
We have determined that the gross unrealized losses on available for sale securities at October 2, 2026 and October 3, 2025 are temporary in nature and/or do not relate to credit loss, therefore there is no expense for credit losses recorded in our Consolidated Statements of Operations. The techniques used to measure the fair value of our investments are described in Note 2 - Summary of Significant Accounting Policies. We review our investments to identify and evaluate investments that have indications of possible impairment due to credit loss. Factors considered in determining whether a loss is due to credit loss include the extent to which fair value has been less than the cost basis, adverse conditions, the financial condition and near-term prospects of the investee, and our intent and ability to hold the investment for a period of time sufficient to allow for any anticipated recovery in market value. All of our fixed income securities are rated investment grade as of October 2, 2026.
During the fiscal years ended October 2, 2026, October 3, 2025 and September 27, 2024, we received proceeds from sales and maturities of available-for-sale securities of $249.8 million, $360.2 million and $344.8 million, respectively. The gross realized gains and losses of available-for-sale investments were immaterial in fiscal years 2026, 2025 and 2024 and were recorded within Interest income as presented in our Consolidated Statements of Operations.
During the fiscal years ended October 2, 2026, October 3, 2025 and September 27, 2024, interest income on cash and cash equivalents and short-term investments was $29.8 million, $29.9 million and $23.0 million, respectively.
Long-Term Investments
On May 28, 2026, we completed an investment in IQE plc (“Investee”), which included entering into a Subscription Agreement to purchase newly-issued ordinary shares of Investee (representing approximately 12% of Investee’s issued and outstanding ordinary shares on the date of issuance), for £30.0 million ($40.4 million) (“Equity Investment”), a five-year Convertible Loan Note Agreement with a principal balance of £15.0 million ($20.2 million) (“Debt Investment”, collectively, “Long-Term Investments”) and long-term supply agreements. The Debt Investment has a zero-coupon rate and is expected to be repaid beginning on the third anniversary of the issuance. The Debt Investment is convertible into Investee ordinary shares at a conversion price equal to the same price per share as was paid in the Equity Investment. The conversion option is available if the Debt Investment is repaid prior to the contractual maturity date, based on the occurrence of certain contingent events. Warrants for shares of Investee’s ordinary shares were issued as part of the Debt Investment, which become exercisable in lieu of conversion under the early repayment terms. In accordance with ASC 323, Investments - Equity Method and Joint Ventures, and upon consideration of the totality of our agreements, including our right to appoint two members to Investee’s board of directors, we concluded the Equity Investment is an equity method investment. We have elected to account for the Long-Term Investments using the fair value option for simplification. The Long-Term Investments are recorded within Long-term investments on the consolidated balance sheet, and changes in fair value are recorded through Gain on investment fair value within the consolidated statements of operations. The Equity Investment is valued using a market approach and the Debt Investment is valued using an income approach based on contractual future cash flows discounted to present value as of the last day of our fiscal year.
As of October 2, 2026, the Equity Investment and Debt Investment were recorded at their fair values of $109.9 million and $11.7 million, respectively, and the fair value of the warrants was not material. During the fiscal year ended October 2, 2026, we recorded a net gain of $61.0 million on Long-Term Investments, comprised of a gain of $69.5 million on the Equity Investment and a loss of $8.5 million on the Debt Investment.
6. FAIR VALUE AND FINANCIAL INSTRUMENTS
Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis
We measure certain assets and liabilities at fair value on a recurring basis such as our financial instruments. There have been no transfers between Level 1, 2 or 3 assets or liabilities during the fiscal years ended October 2, 2026 and October 3, 2025.
Assets and liabilities measured at fair value on a recurring basis consist of the following (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | |
| October 2, 2026 |
| Fair Value | | Active Markets for Identical Assets (Level 1) | | Observable Inputs (Level 2) | | Unobservable Inputs (Level 3) |
| Assets | | | | | | | |
| Money market funds | $ | 62,741 | | | $ | 62,741 | | | $ | — | | | $ | — | |
| | | | | | | |
| U.S. Treasuries and agency bonds | 46,899 | | | 25,887 | | | 21,012 | | | — | |
| Corporate bonds | 633,497 | | | — | | | 633,497 | | | — | |
| | | | | | | |
| Marketable equity securities | 109,883 | | | 109,883 | | | — | | | — | |
| Non-marketable debt securities | 11,694 | | | — | | | 11,694 | | | — | |
| Total assets measured at fair value | $ | 864,714 | | | $ | 198,511 | | | $ | 666,203 | | | $ | — | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
| October 3, 2025 |
| Fair Value | | Active Markets for Identical Assets (Level 1) | | Observable Inputs (Level 2) | | Unobservable Inputs (Level 3) |
| Assets | | | | | | | |
| Money market funds | $ | 63,811 | | | $ | 63,811 | | | $ | — | | | $ | — | |
| | | | | | | |
| U.S. Treasuries and agency bonds | 66,738 | | | 45,373 | | | 21,365 | | | — | |
| Corporate bonds | 557,579 | | | — | | | 557,579 | | | — | |
| Commercial paper | 49,516 | | | — | | | 49,516 | | | — | |
| Total assets measured at fair value | $ | 737,644 | | | $ | 109,184 | | | $ | 628,460 | | | $ | — | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Derivatives
We have foreign currency exposure arising from certain of our Euro and Yen denominated intercompany debt. We have entered into foreign currency exchange hedging contracts associated with this debt to partially mitigate the impact of currency rate changes. They are not designated as cash flow or fair value hedges under ASC 815. Changes in fair value are reported in current period earnings. These gains and losses are intended to offset the gains and losses recorded on the associated intercompany debt. We do not use derivative financial instruments for trading or speculation purposes.
As of October 2, 2026 and October 3, 2025, we had $65.0 million and $36.0 million, respectively in notional forward foreign currency contracts, which were denominated in Euro and Yen. As of October 2, 2026 and October 3, 2025, the fair value of derivative instruments not designated as hedges was immaterial.
7. ACCOUNTS RECEIVABLE ALLOWANCES
Summarized below is the activity in our accounts receivable allowances, including compensation credits and doubtful accounts as follows (in thousands):
| | | | | | | | | | | | | | | | | |
| Fiscal Years |
| 2026 | | 2025 | | 2024 |
| Balance - beginning of year | $ | 886 | | | $ | 2,662 | | | $ | 2,004 | |
| Provision, net | 4,112 | | | 1,954 | | | 5,404 | |
| Charge-offs | (3,222) | | | (3,730) | | | (4,746) | |
| Balance - end of year | $ | 1,776 | | | $ | 886 | | | $ | 2,662 | |
The balances at the end of fiscal years 2026, 2025 and 2024 are comprised primarily of pricing program credits of $1.1 million, $0.7 million and $2.4 million, respectively.
The allowance for doubtful accounts is immaterial as of October 2, 2026, October 3, 2025 and September 27, 2024. We generate accounts receivable from customers and they are classified as short-term. We monitor collections and maintain a provision for expected credit losses based on historical trends, current conditions, and relevant forecasted information, in addition to provisions established for any specific collection issues that have been identified.
8. INVENTORIES
Inventories consist of the following (in thousands):
| | | | | | | | | | | |
| October 2, 2026 | | October 3, 2025 |
| Raw materials | $ | 182,212 | | | $ | 153,196 | |
| Work-in-process | 44,428 | | | 32,973 | |
| Finished goods | 57,671 | | | 51,675 | |
| Total | $ | 284,311 | | | $ | 237,844 | |
9. PROPERTY AND EQUIPMENT
Property and equipment consists of the following (in thousands):
| | | | | | | | | | | |
| October 2, 2026 | | October 3, 2025 |
| Buildings | $ | 30,000 | | | $ | 30,932 | |
| Computer equipment | 21,341 | | | 19,670 | |
| Construction in process | 54,601 | | | 27,460 | |
| Finance lease assets | 38,966 | | | 38,966 | |
| Furniture and fixtures | 4,575 | | | 4,295 | |
| Land | 24,412 | | | 24,871 | |
| Leasehold improvements | 39,785 | | | 38,359 | |
| Machinery and equipment | 346,416 | | | 318,650 | |
| Total property and equipment | 560,096 | | | 503,203 | |
| Less accumulated depreciation and amortization | (308,137) | | | (272,912) | |
| Property and equipment — net | $ | 251,959 | | | $ | 230,291 | |
Depreciation and amortization expense related to property and equipment for fiscal years 2026, 2025 and 2024 was $37.9 million, $31.5 million and $30.1 million, respectively. Accumulated amortization on finance lease assets as of October 2, 2026 and October 3, 2025 was $11.9 million and $10.3 million, respectively.
In August 2022, the U.S. government enacted the CHIPS and Science Act of 2022 (the “CHIPS Act”), which provides funding for manufacturing grants and research investments and established a 25% investment tax credit (“ITC”) for certain qualifying investments in U.S. semiconductor manufacturing equipment. As part of the federal tax and spending legislation enacted on July 4, 2025 (the “2025 Bill”), this ITC was increased to 35% for assets placed into service after December 31, 2025. We account for the ITC as a reduction to the carrying value of the qualifying asset and record a corresponding receivable for expected tax credits in connection with the CHIPS Act. As of October 2, 2026 and October 3, 2025, we have reduced the gross carrying amounts of the qualifying assets in the Consolidated Balance Sheets by $11.5 million and $5.6 million, respectively, as a result of expected tax credits in connection with the CHIPS Act.
10. INTANGIBLE ASSETS
Amortization expense related to intangible assets is as follows (in thousands):
| | | | | | | | | | | | | | | | | |
| Fiscal Years |
| 2026 | | 2025 | | 2024 |
| Cost of revenue | $ | 6,486 | | | $ | 14,333 | | | $ | 14,790 | |
| Research and development | 10,519 | | | 8,892 | | | 4,763 | |
| Selling, general and administrative | 7,741 | | | 8,527 | | | 17,612 | |
| Total | $ | 24,746 | | | $ | 31,752 | | | $ | 37,165 | |
A summary of the activity in gross intangible assets as of October 2, 2026 and October 3, 2025 is as follows (in thousands):
| | | | | | | | | | | | | | | | | | | | |
| October 2, 2026 | |
| Gross Carrying Amount | | | | Accumulated Amortization | | Net Carrying Amount | |
| Acquired technology | $ | 34,818 | | | | | $ | (21,279) | | | $ | 13,539 | | |
| | | | | | | | |
| Customer relationships | 53,435 | | | | | (26,922) | | | 26,513 | | |
| Software licenses and licensed technology | 30,414 | | | | | (16,816) | | | 13,598 | | |
Trade name (1) | 5,200 | | | | | (930) | | | 4,270 | | |
Balance as of October 2, 2026 (2) | $ | 123,867 | | | | | $ | (65,947) | | | $ | 57,920 | | |
| | | | | | | | | | | | | | | | | | | |
| October 3, 2025 |
| Gross Carrying Amount | | | | Accumulated Amortization | | Net Carrying Amount |
| Acquired technology | $ | 34,994 | | | | | $ | (14,859) | | | $ | 20,135 | |
| | | | | | | |
| Customer relationships | 74,572 | | | | | (41,304) | | | 33,268 | |
| | | | | | | |
| Software licenses | 26,186 | | | | | (5,544) | | | 20,642 | |
Trade name (1) | 5,200 | | | | | (675) | | | 4,525 | |
Balance as of October 3, 2025 (2) | $ | 140,952 | | | | | $ | (62,382) | | | $ | 78,570 | |
(1) Includes an indefinite-lived trade name of $3.4 million that is not amortized.
(2) Foreign intangible asset carrying amounts include foreign currency translation adjustments.
Fully amortized intangible assets of $21.1 million and $138.8 million were eliminated from both gross and accumulated amortization amounts in the fourth quarter of fiscal years 2026 and 2025, respectively.
As of October 2, 2026, our estimated amortization of our intangible assets in future fiscal years, was as follows (in thousands):
| | | | | | | | | | | | | | | | | | | | |
| 2027 | 2028 | 2029 | 2030 | 2031 | Thereafter |
| Amortization expense | $ | 23,218 | | $ | 10,932 | | $ | 5,940 | | $ | 5,216 | | $ | 3,948 | | $ | 5,266 | |
The weighted-average amortization period for total intangible assets acquired during fiscal year 2026 is 2.6 years.
The following table presents a summary of the changes in goodwill during fiscal years 2026 and 2025 (in thousands):
| | | | | | | | | | | | |
| Fiscal Years | |
| 2026 | | 2025 | |
| Balance at beginning of year | $ | 336,315 | | | $ | 332,201 | | |
| Acquired | (6) | | | 4,263 | | |
| Foreign currency translation adjustment | (604) | | | (149) | | |
| Balance at end of year | $ | 335,705 | | | $ | 336,315 | | |
11. ACCRUED LIABILITIES
Accrued liabilities consist of the following (in thousands):
| | | | | | | | | | | |
| October 2, 2026 | | October 3, 2025 |
| Compensation and benefits | $ | 64,930 | | | $ | 48,236 | |
| Current portion of operating leases | 6,525 | | | 6,284 | |
| Contract liabilities | 1,411 | | | 7,676 | |
| Software licenses and licensed technology | 10,401 | | | 9,889 | |
| Other | 27,622 | | | 23,874 | |
| Total accrued liabilities | $ | 110,889 | | | $ | 95,959 | |
12. PRODUCT WARRANTIES
We establish a product warranty liability at the time of revenue recognition. Product warranties generally have terms of 12 months and cover nonconformance with specifications and defects in material or workmanship. For sales to distributors, our warranty generally begins when the product is resold by the distributor. The liability is based on estimated costs to fulfill customer product warranty obligations and utilizes historical product failure rates. Should actual warranty obligations differ from estimates, revisions to the warranty liability may be required.
Product warranty liability activity is as follows (in thousands):
| | | | | | | | | | | | | | | | | |
| | | Fiscal Years | | |
| 2026 | | 2025 | | 2024 |
| Balance — beginning of year | $ | 1,429 | | | $ | 725 | | | $ | 1,016 | |
| Provisions | 1,915 | | | 1,670 | | | 1,429 | |
| Warranty claims | (1,415) | | | (966) | | | (1,720) | |
| | | | | |
| Balance — end of year | $ | 1,929 | | | $ | 1,429 | | | $ | 725 | |
13. EMPLOYEE BENEFIT PLANS
On October 1, 2009, we established a defined contribution savings plan under Section 401(k) of the Internal Revenue Code of 1986, as amended (the “401(k) Plan”). The 401(k) Plan follows a calendar year, covers substantially all U.S. employees who meet minimum age and service requirements and allows participants to defer a portion of their annual compensation on a pretax basis, subject to legal limitations. Our contributions to the 401(k) Plan may be made at the discretion of the board of directors. During the fiscal years ended October 2, 2026, October 3, 2025 and September 27, 2024, we contributed $5.2 million, $4.3 million and $5.9 million to our 401(k) Plan for calendar years 2026, 2025 and 2024, respectively.
Our employees located in foreign jurisdictions meeting minimum age and service requirements participate in defined contribution plans whereby participants may defer a portion of their annual compensation on a pretax basis, subject to legal limitations. We expensed contributions of $3.7 million, $2.4 million and $2.1 million for fiscal years 2026, 2025 and 2024, respectively.
14. COMMITMENTS AND CONTINGENCIES
Asset Retirement Obligations—We are obligated under certain facility leases to restore those facilities to the condition in which we or our predecessors first occupied the facilities. We are required to remove leasehold improvements and equipment installed in these facilities prior to termination of the leases. As of October 2, 2026 and October 3, 2025, the estimated cost for the removal of these assets that are recorded as asset retirement obligations in other long-term liabilities in our Consolidated Balance Sheets was $1.9 million.
Purchase Commitments—As of October 2, 2026, we had outstanding purchase commitments of $328.8 million primarily for purchases of services and inventory supply arrangements of which approximately $301.7 million are payments due within one year.
Litigation—From time to time we may be subject to commercial disputes, employment issues, claims by other companies in the industry that we have infringed their intellectual property rights and other similar claims and litigation. Any such claims may lead to future litigation and material damages and defense costs. We were not involved in any material legal proceedings during the fiscal year ended October 2, 2026.
15. DEBT
The following represents the outstanding balances and effective interest rates (in thousands, except percentages):
| | | | | | | | | | | | | | | | | |
| October 2, 2026 | | October 3, 2025 |
| Principal Balance | Effective Interest Rate | | Principal Balance | Effective Interest Rate |
| 0.00% convertible notes due December 2029 | $ | 344,316 | | 0.33 | % | | $ | 344,316 | | 0.33 | % |
0.25% convertible notes due March 2026 | — | | — | | | 161,151 | | 0.54 | % |
| Total principal amount outstanding | 344,316 | | | | 505,467 | | |
| Unamortized deferred financing costs | (3,573) | | | | (4,891) | | |
| Less: Current portion of long term debt | 340,743 | | | | 160,946 | | |
| Total long-term debt | $ | — | | | | $ | 339,630 | | |
Interest expense for our convertible notes is as follows (in thousands):
| | | | | | | | | | | | | | | | | |
| | | Fiscal Years | | |
| 2026 | | 2025 | | 2024 |
| Coupon interest | $ | 179 | | | $ | 560 | | | $ | 1,122 | |
| Amortization of issuance costs | 1,318 | | | 1,449 | | | 1,146 | |
| Total interest expense | $ | 1,497 | | | $ | 2,009 | | | $ | 2,268 | |
2029 Convertible Notes
On December 19, 2024, we issued 0.00% convertible senior notes due in fiscal year 2030, pursuant to an indenture dated as of such date (the “2024 Indenture”), between the Company and U.S. Bank Trust Company, National Association, as trustee with an aggregate principal amount of $344.3 million (the “2029 Convertible Notes”).
Holders of the 2029 Convertible Notes may convert their notes at their option at any time prior to the close of business on the business day immediately preceding September 15, 2029 in multiples of $1,000 principal amount, only under the following circumstances: (i) during any fiscal quarter commencing after the fiscal quarter ending on April 4, 2025 (and only during such fiscal quarter), if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the notes on each applicable trading day (the “Stock Price Trigger”); (ii) during the five business day period after any five consecutive trading day period (the “Measurement Period”) in which the “trading price” (as defined in the 2024 Indenture) per $1,000 principal amount of the notes for each trading day of the Measurement Period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate for the notes on each such trading day; (iii) if we call such notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or (iv) upon the occurrence of specified corporate events described in the 2024 Indenture. On or after September 15, 2029 until the close of business on the second scheduled trading day immediately preceding the maturity date, the holders may convert their notes, in multiples of $1,000 principal amount, regardless of the foregoing circumstances.
The initial conversion rate for the 2029 Convertible Notes is 5.7463 shares of common stock (subject to adjustment as provided for in the 2024 Indenture) per $1,000 principal amount of the notes, which is equal to an initial conversion price of approximately $174.03 per share of common stock.
The 2029 Convertible Notes do not bear regular interest, and the principal amount of the notes does not accrete. The notes are senior unsecured obligations of the Company and will mature on December 15, 2029, unless earlier redeemed, repurchased or converted. Upon conversion of the 2029 Convertible Notes, we are required to pay cash up to the aggregate principal amount of the notes to be converted and pay or deliver, as the case may be, cash, shares of our common stock or a combination of cash and shares of our common stock, at our election, in respect of the remainder, if any, of our conversion obligation in excess of the aggregate principal amount of the notes being converted (subject to, and in accordance with, the settlement provisions of the 2024 Indenture). We must notify the holders of the 2029 Convertible Notes of our settlement method for our conversion obligation in excess of the aggregate principal amount no later than September 15, 2029, for conversions occurring on or after that date. We may redeem for cash all or any portion of the notes, at our option, on or after December 20, 2027 and prior to September 15, 2029 if the last reported sale price per share of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive), including the trading day immediately preceding the date on which we provide notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest, to, but not including, the redemption date.
The 2024 Indenture does not contain any financial or operating covenants or restrictions on the payments of dividends, the making of investments, the incurrence of indebtedness or the purchase or prepayment of securities by us or any of our subsidiaries.
During the fiscal quarter ended October 2, 2026, the Stock Price Trigger was satisfied, and as a result, holders of our 2029 Convertible Notes may convert their notes at their option at any time during the subsequent first fiscal quarter ending January 1, 2027, and the 2029 Convertible Notes balance of $340.7 million, net of deferred financing costs, is classified as short-term debt in our Consolidated Balance Sheet.
The fair value of our 2029 Convertible Notes, including the conversion feature, was $687.3 million and $353.3 million as of October 2, 2026 and October 3, 2025, respectively, and was determined based on quoted prices in markets that are not active, which is considered a Level 2 valuation input.
The full principal amount of the 2029 Convertible Notes of $344.3 million is due on December 15, 2029.
2026 Convertible Notes
On March 25, 2021, we issued 0.25% convertible senior notes due in fiscal year 2026, pursuant to an indenture dated as of such date (the “2021 Indenture”), between the Company and U.S. Bank National Association, as trustee, with an aggregate principal amount of $400.0 million (the “Initial Notes”), and on April 6, 2021, we issued an additional $50.0 million aggregate principal amount (the “Additional Notes”) (together, the “2026 Convertible Notes”). The Additional Notes were issued and sold to the initial purchaser of the Initial Notes, pursuant to the option to purchase the Additional Notes granted by the Company to the initial purchaser and have the same terms as the Initial Notes.
On December 12, 2024, we entered into separate, privately negotiated exchange and subscription agreements (the “Exchange and Subscription Agreements”) with a limited number of holders of the 2026 Convertible Notes. Under the terms of the Exchange and Subscription Agreements, the holders exchanged $288.8 million in aggregate principal amount of 2026 Convertible Notes held by them for $257.7 million of our 2029 Convertible Notes (defined above), 1,582,958 newly-issued shares of the Company’s common stock, par value $0.001 per share, issued at a fair value of $205.9 million, and $17.6 million in cash (collectively, the “Exchanges”). The Exchanges resulted in aggregate pre-tax debt extinguishment charges of $193.1 million. The Company also issued approximately $86.6 million in additional aggregate principal amount of the 2029 Convertible Notes in a private placement to certain investors (the “Subscription” and, together with the Exchanges, the “Transactions”). The Transactions closed on December 19, 2024. Following the closing of the Transactions, the aggregate principal balance of the 2026 Convertible Notes was $161.2 million and the terms of the 2021 Indenture were unchanged.
In September 2025, certain holders exercised their right to convert $0.5 million of the notes. The transaction settled during the first fiscal quarter of 2026 and we paid $0.5 million principal in cash and issued 2,610 shares of our common stock for the conversion premium, par value $0.001 per share, issued at a fair value of $0.5 million. On March 16, 2026, pursuant to the terms of the 2021 Indenture, we settled the remaining 2026 Convertible Notes and paid the total outstanding principal balance of $160.7 million in cash and issued 1,259,111 shares of our common stock for the conversion premium, par value $0.001 per share, issued at a fair value of $283.2 million. There was no gain or loss recognized for these transactions in our consolidated statements of operations and there was an immaterial amount recognized in additional paid-in capital in our consolidated balance sheets for these transactions.
The fair value of the 2026 Convertible Notes, including the conversion feature, was $251.6 million as of October 3, 2025 and was determined based on quoted prices in markets that are not active, which is considered a Level 2 valuation input.
16. FINANCING OBLIGATION
Power Purchase Agreement
We are party to a power purchase agreement for the use of electric power and thermal energy producing systems at our fabrication facility in Lowell, Massachusetts. This system is expected to reduce our consumption of energy while delivering sustainable, resilient energy for heating and cooling. We do not own these systems; however, we control the use of the assets during operation. As of October 2, 2026 and October 3, 2025, the asset in Property and equipment, net was $6.9 million and $7.5 million, respectively, and the corresponding liability was $8.7 million and $9.0 million, respectively, classified primarily in Financing obligation on our Consolidated Balance Sheets. The financing obligation was calculated based on future fixed payments allocated to the power generator of $16.8 million over the 15-year term, discounted at an implied discount rate of 7.4%, and the remaining future minimum payments are for power purchases. As of October 2, 2026, we have $20.6 million in remaining fixed payments over a remaining 11-year term, of which $12.9 million, discounted to $8.7 million, is included in our consolidated balance sheets.
Sale-Leaseback
In connection with the RF Business Acquisition, the Seller granted MACOM a right of first offer to purchase the RTP Fab property. MACOM exercised this right and subsequently assigned it to a third-party, who completed the purchase of the property during the fiscal year ended October 3, 2025. Simultaneously, we entered into a 12-year lease agreement with the third-party to lease the RTP Fab property. This lease also includes two consecutive renewal options, each for a term of ten years.
The lease between MACOM and the third-party is considered a failed sale-leaseback for accounting purposes as we have the option to purchase the property during the lease term. Accordingly, we recognized the fair value of the RTP Fab property within Property and Equipment, net, allocated to land and building, and recorded a corresponding liability classified in Financing Obligation on the consolidated balance sheets. The financing obligation was calculated based on future fixed lease payments over the expected term, discounted at an incremental borrowing rate of 7.4%.
The building will be depreciated over the remaining useful life. Lease payments under the agreement are recognized as interest expense and a reduction of the financing obligation over the term of the agreement. As of October 2, 2026 and October 3, 2025, the net book value of the land and building in property and equipment, net was $28.1 million and $28.6 million, respectively, and the corresponding liability was $28.4 million and $28.5 million, respectively.
As of October 2, 2026, expected future minimum payments for the financing obligations were as follows (in thousands):
| | | | | | | | | | | |
| Fiscal year ending: | | Sale-Leaseback | Power Purchase Agreement |
| 2027 | | $ | 2,312 | | $ | 1,031 | |
| 2028 | | 2,347 | | 1,057 | |
| 2029 | | 2,382 | | 1,084 | |
| 2030 | | 2,418 | | 1,110 | |
| 2031 | | 2,454 | | 1,138 | |
| Thereafter | | 14,613 | | 7,525 | |
| Total payments | | 26,526 | | 12,945 | |
| Less: interest | | (20,763) | | (4,291) | |
| Plus: residual value | | 22,596 | | — | |
| Present value of financing obligations | | $ | 28,359 | | $ | 8,654 | |
17. LEASES
Included in our Consolidated Balance Sheets were the following amounts related to operating and finance lease assets and liabilities (in thousands):
| | | | | | | | | | | | | | | | | |
| | October 2, 2026 | | October 3, 2025 | Consolidated Balance Sheets Classification |
| Assets: | | | | | |
| Operating lease ROU assets | | $ | 32,484 | | | $ | 31,883 | | Other long-term assets |
| Finance lease assets | | 27,114 | | | 28,701 | | Property and equipment, net |
| | | | | |
| Total lease assets | | $ | 59,598 | | | $ | 60,584 | | |
| Liabilities: | | | | | |
| Current: | | | | | |
| Operating lease liabilities | | $ | 6,525 | | | $ | 6,284 | | Accrued liabilities |
| Finance lease liabilities | | 707 | | | 626 | | Current portion of finance lease obligations |
| | | | | |
| Long-term: | | | | | |
| Operating lease liabilities | | 29,074 | | | 28,448 | | Other long-term liabilities |
| Finance lease liabilities | | 29,796 | | | 30,504 | | Finance lease obligations, less current portion |
| | | | | |
| Total lease liabilities | | $ | 66,102 | | | $ | 65,862 | | |
The weighted-average remaining lease terms and weighted-average discount rates for operating and finance leases were as follows:
| | | | | | | | |
| October 2, 2026 | October 3, 2025 |
| Weighted-average remaining lease term (in years): | | |
| Operating leases | 6.4 | 7.1 |
| Finance leases | 17.1 | 18.1 |
| Weighted-average discount rate: | | |
| Operating leases | 6.2 | % | 6.3 | % |
| Finance leases | 6.7 | % | 6.7 | % |
The components of lease expense were as follows (in thousands):
| | | | | | | | | | | |
| Fiscal Year Ended |
| October 2, 2026 | October 3, 2025 | September 27, 2024 |
| Finance lease cost: | | | |
| Amortization of lease assets | $ | 1,587 | | $ | 1,788 | | $ | 2,332 | |
| Interest on lease liabilities | 2,054 | | 2,141 | | 2,160 | |
| Total finance lease cost | $ | 3,641 | | $ | 3,929 | | $ | 4,492 | |
| | | |
| Operating lease cost | $ | 9,239 | | $ | 9,438 | | $ | 10,280 | |
| Variable lease cost | $ | 3,793 | | $ | 3,389 | | $ | 3,604 | |
| Short-term lease cost | $ | 1,163 | | $ | 289 | | $ | 36 | |
| Sublease income | $ | 425 | | $ | 426 | | $ | 1,324 | |
Cash paid for amounts included in the measurement of lease liabilities were as follows (in thousands):
| | | | | | | | | | | |
| Fiscal Year Ended |
| October 2, 2026 | October 3, 2025 | September 27, 2024 |
| Cash paid for amounts included in measurement of lease liabilities: | | | |
| Operating cash flows from operating leases | $ | 8,944 | | $ | 9,247 | | $ | 10,567 | |
| Operating cash flows from finance leases | $ | 2,054 | | $ | 2,141 | | $ | 2,160 | |
| Financing cash flows from finance leases | $ | 626 | | $ | 741 | | $ | 1,175 | |
| | | |
| Non-cash activities: | | | |
| Operating lease ROU assets obtained in exchange for new lease liabilities | $ | 7,639 | | $ | 10,363 | | $ | 10,643 | |
| | | |
As of October 2, 2026, maturities of lease payments by fiscal year were as follows (in thousands):
| | | | | | | | | | | | | | |
| Fiscal year ending: | | Operating Leases | | Finance Leases |
| 2027 | | $ | 8,521 | | | $ | 2,718 | |
| 2028 | | 7,091 | | | 2,754 | |
| 2029 | | 6,052 | | | 2,803 | |
| 2030 | | 4,998 | | | 2,842 | |
| 2031 | | 4,463 | | | 2,880 | |
| Thereafter | | 12,628 | | | 38,339 | |
| Total lease payments | | 43,753 | | | 52,336 | |
| Less: interest | | (8,154) | | | (21,833) | |
| Present value of lease liabilities | | $ | 35,599 | | | $ | 30,503 | |
18. STOCKHOLDERS’ EQUITY
We have authorized 10.0 million shares of $0.001 par value preferred stock and 300.0 million shares of $0.001 par value common stock as of October 2, 2026 and October 3, 2025.
19. SHARE-BASED COMPENSATION PLANS
Stock Plans
We have two equity incentive plans: the 2021 Omnibus Incentive Plan (“2021 Plan”) and the 2021 Employee Stock Purchase Plan (“2021 ESPP”).
We have outstanding awards under the 2021 Plan. Under the 2021 Plan, we have the ability to issue incentive stock options (“ISOs”), non-statutory stock options (“NSOs”), stock appreciation rights (“SARs”), restricted stock awards (“RSAs”), unrestricted stock awards, stock units (including restricted stock units (“RSUs”) and performance-based restricted stock units (“PRSUs”)), performance awards, cash awards, and other share-based awards to employees, directors, consultants and advisors. The ISOs and NSOs must be granted at an exercise price, and the SARs must be granted at a base value, per share of not less than 100% of the closing price of a share of our common stock on the date of grant (or, if no closing price is reported on that date, the closing price on the immediately preceding date on which a closing price was reported) (110% in the case of certain ISOs). Options granted primarily vested based on certain market-based and performance-based criteria as described below and generally have a term of four to seven years. Certain of the share-based awards granted and outstanding as of October 2, 2026, are subject to accelerated vesting upon a sale of the Company or similar changes in control.
As of October 2, 2026, we had 2.5 million shares available for future issuance under the 2021 Plan and 0.9 million shares available for issuance under our 2021 ESPP.
Incentive Stock Units
Outside of the two equity plans described above, we also grant incentive stock units (“ISUs”) to certain of our international employees which typically vest over three years for which the fair value is determined by our underlying stock price, which are classified as liabilities and settled in cash upon vesting.
During fiscal years 2026, 2025 and 2024, the fair value of ISU awards granted was $2.2 million, $1.9 million and $2.2 million, respectively. ISU awards were paid out at a fair value of $3.7 million, $4.2 million and $2.0 million for the fiscal years 2026, 2025 and 2024, respectively. As of October 2, 2026 and October 3, 2025, the fair value of outstanding awards was $9.9 million and $5.1 million, respectively, and the associated accrued compensation liability was $7.1 million and $3.7 million, respectively.
During fiscal years 2026, 2025 and 2024, we recorded an expense for these ISU awards of $6.9 million, $3.2 million and $3.3 million, respectively. These expenses are not included in the share-based compensation expense totals below.
Employee Stock Purchase Plan
The 2021 ESPP allows eligible employees to purchase shares of our common stock at a discount through payroll deductions of up to 15% of their eligible compensation, subject to any plan limitations. In administering the 2021 ESPP, the board of directors has limited discretion to set the length of the offering periods thereunder. In fiscal years 2026, 2025 and 2024, 95,546, 106,615 and 116,346 shares of common stock were issued under the 2021 ESPP, respectively.
Share-Based Compensation
The following table shows a summary of share-based compensation expense included in the Consolidated Statements of Operations during the periods presented (in thousands):
| | | | | | | | | | | | | | | | | |
| Fiscal Years |
| 2026 | | 2025 | | 2024 |
| Cost of revenue | $ | 10,500 | | | $ | 8,524 | | | $ | 5,938 | |
| Research and development | 33,072 | | | 32,144 | | | 18,072 | |
| Selling, general and administrative | 44,225 | | | 38,694 | | | 21,634 | |
| Total | $ | 87,797 | | | $ | 79,362 | | | $ | 45,644 | |
As of October 2, 2026, the total unrecognized compensation costs related to outstanding restricted stock awards and units including awards with time-based, performance-based, and market-based vesting was $97.9 million, which we expect to recognize over a weighted-average period of 1.8 years. As of October 2, 2026, total unrecognized compensation cost related to the 2021 ESPP was $0.6 million.
Restricted Stock Awards and Units
A summary of RSU and PRSU activity for fiscal year 2026 is as follows (in thousands, except per share amounts):
| | | | | | | | | | | | | |
| Number of Shares | | Weighted-Average Grant Date Fair Value | | |
| Issued and unvested - October 3, 2025 | 1,419 | | | $ | 97.19 | | | |
| | | | | |
| Granted | 544 | | | 172.00 | | | |
Performance-based adjustment (1) | 201 | | | 85.93 | | | |
| Vested | (869) | | | 84.08 | | | |
| Forfeited, canceled or expired | (84) | | | 117.46 | | | |
| Issued and unvested - October 2, 2026 | 1,211 | | | $ | 136.96 | | | |
| | | | | |
(1) The amount shown represents performance adjustments for performance-based awards. These were granted in prior fiscal years and vested during fiscal year 2026 based on the Company’s achievement of adjusted earnings per share and total shareholder return performance conditions.
The weighted-average grant date fair value per share for restricted stock awards and units, inclusive of PRSUs, granted during the fiscal years 2026, 2025 and 2024, was $172.00, $127.24 and $80.42, respectively. The total fair value of restricted stock awards and units vested, inclusive of PRSUs, was $151.8 million, $119.1 million and $42.8 million for fiscal years 2026, 2025 and 2024, respectively. RSUs granted generally vest over a period of three years.
Performance-Based Equity Incentives
We issue PRSUs with specific performance vesting criteria. These PRSUs have both a service and performance-based vesting condition and awards are typically divided into three equal tranches and vest based on achieving certain adjusted earnings per share growth metrics. The service condition requires participants to be employed in November following the performance period in which the performance condition was met, when the Company's annual financial performance is announced to the financial markets. Depending on the actual performance achieved, a participant may earn between 0% to 300% of the target number of shares for each tranche, which is determined based on a straight-line interpolation applied for the achievement between the specified performance ranges.
During fiscal year 2026, we granted 54,013 PRSUs and 8,979 PRSUs were forfeited. The weighted-average grant date fair value per share for PRSUs granted during the fiscal years 2026, 2025 and 2024 was $150.37, $115.57 and $73.01, respectively. During fiscal year 2026, the performance condition for 59,962 target shares issued in prior years were earned at 72%, 167% and 300%, and as a result a total of 102,630 shares vested in November 2025 when the service condition was achieved. The total fair value of PRSUs vested was $17.1 million, $1.4 million and $7.9 million in fiscal years 2026, 2025 and 2024, respectively. As of October 2, 2026, the total amount of PRSU awards that could ultimately vest if all performance criteria are achieved would be 320,346 shares assuming a maximum of 300% of the target shares.
Market-based PRSUs
We also issue PRSUs with specific market-based performance vesting criteria. Recipients may earn between 0% and 200% of the target number of shares based on the Company's achievement of total stockholder return in comparison to a peer group of companies in the Nasdaq composite index over a period of approximately three years. The fair value of the awards was estimated using a Monte Carlo simulation and compensation expense is recognized ratably over the service period based on the grant date fair value of the awards subject to the market condition. The expected volatility of the Company's common stock was estimated based on the historical average volatility rate over the three-year period. The dividend yield assumption was based on historical and anticipated dividend payouts. The risk-free rate assumption was based on observed interest rates consistent with the three-year measurement period.
The weighted-average assumptions used to value the awards are as follows:
| | | | | | | | | | | | | | | | | |
| Fiscal Years |
| 2026 | | 2025 | | 2024 |
| Weighted-average grant date fair value | $ | 215.58 | | $ | 168.47 | | $ | 88.88 |
| Assumptions: | | | | | |
| Weighted-average grant date stock price | $ | 151.20 | | $ | 115.69 | | $ | 73.01 |
| Weighted-average stock price at the start of the performance period | $ | 128.76 | | $ | 103.09 | | $ | 79.43 |
| Weighted-average risk free interest rate | 3.5% | | 4.0% | | 4.6% |
| Weighted-average years to maturity | 2.9 | | 2.9 | | 2.9 |
| Weighted-average expected volatility rate | 41.7% | | 39.2% | | 41.7% |
| Weighted-average expected dividend yield | — | | — | | — |
During fiscal year 2026, we granted 108,095 market-based PRSUs and 12,296 market-based PRSUs were forfeited. During fiscal year 2026, the market-based PRSU performance condition for 152,282 target shares issued in prior years were earned at 200%, and as a result a total of 304,564 shares vested in November 2025 when the service condition was achieved. The total fair value of market-based PRSUs vested was $50.8 million and $40.1 million in fiscal years 2026 and 2025, respectively. No market-based PRSUs vested in fiscal year 2024. As of October 2, 2026, the total amount of market-based PRSU awards that could ultimately vest if all performance criteria are achieved would be 655,490 shares assuming a maximum of 200% of the target shares.
Stock Options
As of October 2, 2026, there were no stock options outstanding and exercisable. There were no options exercised during the fiscal year ended October 2, 2026. The total intrinsic value of options exercised during fiscal years 2025 and 2024 was $0.6 million and $0.8 million, respectively. There were no stock options granted for fiscal years 2026, 2025 and 2024.
20. INCOME TAXES
The domestic and foreign income from operations before taxes were as follows (in thousands):
| | | | | | | | | | | | | | | | | |
| Fiscal Years |
| 2026 | | 2025 | | 2024 |
| United States | $ | 369,653 | | | $ | (37,245) | | | $ | 58,090 | |
| Foreign | 20,233 | | | 8,220 | | | 33,436 | |
| Income from operations before income taxes | $ | 389,886 | | | $ | (29,025) | | | $ | 91,526 | |
The components of the provision (benefit) for income taxes are as follows (in thousands):
| | | | | | | | | | | | | | | | | |
| Fiscal Years |
| 2026 | | 2025 | | 2024 |
| Current: | | | | | |
| Federal | $ | 13,584 | | | $ | 15,372 | | | $ | 4,530 | |
| State | 2,347 | | | 794 | | | 1,588 | |
| Foreign | 10,828 | | | 4,524 | | | 3,710 | |
| Current provision | 26,759 | | | 20,690 | | | 9,828 | |
| Deferred: | | | | | |
| Federal | 36,901 | | | (334) | | | 11,165 | |
| State | (1,170) | | | (3,698) | | | (1,417) | |
| Foreign | (3,894) | | | (1,603) | | | (1,294) | |
| Change in valuation allowance | (3,961) | | | 10,130 | | | (3,615) | |
| Deferred provision | 27,876 | | | 4,495 | | | 4,839 | |
| Total provision | $ | 54,635 | | | $ | 25,185 | | | $ | 14,667 | |
We recognize deferred tax assets when realization is more likely than not based on available positive and negative evidence, including recent operating results, reversals of taxable temporary differences, projected future taxable income and tax-planning strategies. In fiscal year 2024, the extension of the California NOL carryforward period resulted in a $3.6 million income tax benefit from a reduction in our valuation allowance. In fiscal year 2025, we increased our valuation allowance by $10.1 million, primarily related to $9.2 million of foreign NOLs determined not to be recoverable and changes in estimated future California taxable income. In fiscal year 2026, we decreased our valuation allowance by $4.0 million, primarily reflecting a valuation allowance release of $9.7 million related to California NOLs that, based on updated estimates of future California taxable income, are more likely than not to be realized before expiration. This decrease was partially offset by an increase in the valuation allowance of $5.7 million related to certain foreign NOLs.
We adopted ASU 2023-09 on a prospective basis beginning with the year ended October 2, 2026. Prior period information has not been restated and is presented under the disclosure requirements in effect during those periods. The following table presents required disclosure pursuant to ASU 2023-09 and reconciles the U.S. federal statutory tax amount and rate to our actual global effective amount and rate for the year ended October 2, 2026 (in thousands, except percent amounts):
| | | | | | | | | | | |
| October 2, 2026 |
| Amount | | Percent |
| Federal statutory rate | $ | 81,876 | | | 21.0 | % |
| Nontaxable or nondeductible items: | | | |
| Share-based compensation - Windfall | (17,418) | | | (4.5) | |
| Disallowed executive compensation | 13,239 | | | 3.4 | |
| Other | (376) | | | (0.1) | |
| Research and development credits | (13,144) | | | (3.4) | |
| Effect of cross-border tax laws | | | |
| Global intangible low taxed income | 4,901 | | | 1.2 | |
| Section 250 deduction for foreign-derived income and net tested income | (2,305) | | | (0.6) | |
| Foreign-derived intangible deduction | (3,216) | | | (0.8) | |
| Disregarded entities | 402 | | | 0.1 | |
| Foreign tax effects | | | |
| Ireland | (8,161) | | | (2.1) | |
| France | 5,610 | | | 1.5 | |
| Other | (752) | | | (0.2) | |
| State and local income tax, net of federal effect | (9,239) | | | (2.4) | |
| Other adjustments: | | | |
| Provision to return adjustments | 4,556 | | | 1.2 | |
| Other | (1,338) | | | (0.3) | |
| Effective income tax rate | $ | 54,635 | | | 14.0 | % |
The following table reconciles the U.S. federal statutory tax rate to our actual global effective rate for the years ended October 3, 2025 and September 27, 2024 in accordance with the guidance prior to the adoption of ASU 2023-09:
| | | | | | | | | | | |
| |
| 2025 | | 2024 |
| Federal statutory rate | 21.0% | | 21.0% |
| Debt exchange | (139.2) | | — |
Benefit from income taxes attributable to valuation allowances | (35.6) | | (4.0) |
| Global intangible low taxed income | (37.7) | | 12.7 |
| Foreign-derived intangible income deduction | 35.7 | | (4.5) |
| Research and development credits | 45.0 | | (9.4) |
| | | |
| Foreign rate differential | 14.2 | | (4.5) |
| Share-based compensation | 7.8 | | 0.1 |
| Provision to return adjustments | 15.5 | | 0.2 |
| State taxes net of federal benefit | (9.8) | | 3.0 |
| | | |
| | | |
| | | |
| | | |
| Other permanent differences | (3.7) | | 1.4 |
| Effective income tax rate | (86.8)% | | 16.0% |
The effective income tax rates for fiscal years 2026, 2025 and 2024 were primarily impacted by a lower income tax rate in many foreign jurisdictions in which our foreign subsidiaries operate, changes in valuation allowance, research and development tax credits and the inclusion of Global Intangible Low Taxed Income. The effective tax rate of fiscal year 2025 was also impacted by non-deductible losses on debt exchange.
Deferred income taxes reflect the net effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and amounts used for income tax purposes. The components of our deferred tax assets and liabilities are as follows (in thousands):
| | | | | | | | | | | |
| October 2, 2026 | | October 3, 2025 |
| Deferred tax assets: | | | |
| Net operating loss and credit carryforward | $ | 120,469 | | | $ | 127,854 | |
| Intangible assets | 22,248 | | | 25,761 | |
| Section 174 R&D Cost Capitalization | 29,068 | | | 51,417 | |
| Accrued expenses | 42,144 | | | 29,066 | |
| Lease obligations | 20,772 | | | 20,820 | |
| Property and equipment | 2,675 | | | — | |
| Minority equity investments | 565 | | | 566 | |
| | | |
| | | |
| Gross deferred tax asset | 237,941 | | | 255,484 | |
| Less valuation allowance | (21,207) | | | (25,168) | |
| Deferred tax asset, net of valuation allowance | 216,734 | | | 230,316 | |
| | | |
| Deferred tax liabilities: | | | |
| Right of use lease asset | (20,614) | | | (21,066) | |
| Long-term investments | (13,778) | | | — | |
| Property and equipment | — | | | (1,251) | |
| Deferred tax liabilities | (34,392) | | | (22,317) | |
| Net deferred tax asset | $ | 182,342 | | | $ | 207,999 | |
As of October 2, 2026, we had $45.2 million of tax-effected federal NOL carryforwards, primarily related to acquisitions made in prior fiscal years. The federal NOL carryforwards will expire at various dates through 2036 for losses generated prior to the tax period ended September 27, 2019. For losses generated during the tax period ended September 27, 2019 and future years, the NOL carryforward period is indefinite but the loss utilization will be limited to 80% of taxable income. The reported NOL carryforward includes any limitation under Sections 382 and 383 of the Internal Revenue Code (“IRC”) of 1986, as amended, which applies to an ownership change as defined under Section 382.
As of October 2, 2026, we had $33.6 million of tax-effected state NOL carryforwards, which expire in fiscal years 2032 through 2044, and deferred tax assets of $16.3 million in France and $5.2 million in Canada, which are offset by valuation allowances of $16.3 million and $4.5 million, respectively. As of October 2, 2026, we also had $26.6 million of state R&D tax credit carryforwards. Our tax credit carryforwards expire in various fiscal years through fiscal year 2045, except for $20.2 million of R&D tax credits that have an indefinite carryforward period.
IRC Section 174 R&D amortization rules, amended as part of the Tax Cuts and Jobs Act of 2017, required capitalization and amortization of all R&D costs incurred in tax years beginning after December 31, 2021. This change was effective for the Company beginning in fiscal year 2023. In July 2025, the U.S. Government enacted the 2025 Bill, which restored the ability to deduct domestic research and development costs in the year they are incurred and no longer requires the deferral and amortization of these costs over five years. For fiscal year 2026, the Company has deducted $112.4 million of domestic research and development costs which were previously capitalized. Costs incurred during fiscal year 2026 relating to R&D performed outside the U.S. are amortized over 15 years. As of October 2, 2026 and October 3, 2025, the deferred tax asset related to IRC Section 174 was $29.1 million and $51.4 million, respectively.
The liability for unrecognized tax benefits was zero as of October 2, 2026, October 3, 2025 and September 27, 2024, and for the fiscal years then ended, we reported no change in unrecognized tax benefits.
A summary of the fiscal tax years that remain subject to examination, as of October 2, 2026, for the Company’s significant tax jurisdictions are:
| | | | | |
| Jurisdiction | Fiscal Years Subject to Examination |
United States—federal | Fiscal Year 2023 - forward |
United States—various states | Fiscal Year 2022 - forward |
Ireland | Fiscal Year 2022 - forward |
We are no longer subject to federal income tax examinations for fiscal years before 2023, except to the extent of loss and tax credit carryforwards from those years. During fiscal year 2026, the Internal Revenue Service commenced an audit of the fiscal year 2024 federal income tax return.
The components of income taxes paid (net of refunds received) for the year ended October 2, 2026 are as follows (in thousands):
| | | | | |
| October 2, 2026 |
| Federal | $ | 5,207 | |
| State and local | 2,416 |
| Foreign | |
| Ireland | 6,336 |
| Taiwan | 1,273 |
| Other foreign jurisdictions | 661 |
| Total income taxes paid, net of refunds | $ | 15,893 | |
Below is a summary of income taxes paid for the years ended October 3, 2025 and September 27, 2024 (in thousands):
| | | | | | | | | | | |
| October 3, 2025 | | September 27, 2024 |
| Cash paid during the year for income taxes, net of refunds | $ | 16,192 | | | $ | 5,997 | |
21. RELATED-PARTY TRANSACTIONS
During the fiscal years ended October 2, 2026 and October 3, 2025, we sold $1.8 million and $0.4 million, respectively, of commercial products to Empower RF Systems, Inc., a MACOM customer, and an affiliate of one of our directors.
Following the closing of our investment in Investee on May 28, 2026, as described in Note 5 - Investments, we purchased $10.3 million of inventory from Investee during the remainder of the fiscal year ended October 2, 2026. As of October 2, 2026, $0.2 million was due to Investee.
During each of the fiscal years ended October 2, 2026 and September 27, 2024, we sold $0.2 million of commercial products to Mission Microwave Technologies, LLC (“Mission”), a MACOM customer and an affiliate of the Company’s President and Chief Executive Officer and Chair of the Board, and an affiliate of one of our directors, each of whom has an equity interest of less than 1% in Mission. There were no sales to Mission during the fiscal year ended October 3, 2025. During the fiscal year ended September 27, 2024, we purchased $0.3 million of machinery and equipment from Gallium Semiconductor, a then affiliate of a former director. There were no purchases from Gallium Semiconductor during the fiscal years ended October 2, 2026 and October 3, 2025.
22. EARNINGS PER SHARE
The following table sets forth the computation for basic and diluted net income (loss) per share of common stock (in thousands, except per share data):
| | | | | | | | | | | | | | | | | |
| Fiscal Years |
| 2026 | | 2025 | | 2024 |
| Numerator: | | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| Net income (loss) attributable to common stockholders | $ | 335,251 | | | $ | (54,210) | | | $ | 76,859 | |
| | | | | |
| Denominator: | | | | | |
| Weighted average common shares outstanding-basic | 75,702 | | | 73,986 | | | 71,959 | |
Dilutive effect of stock options, restricted stock awards and restricted stock units(1) | 1,014 | | | — | | | 954 | |
Dilutive effect of convertible debt(1) | 1,019 | | | — | | | 662 | |
| Weighted average common shares outstanding-diluted | 77,735 | | | 73,986 | | | 73,575 | |
| | | | | |
| | | | | |
| | | | | |
| Net income (loss) to common stockholders per share-basic | $ | 4.43 | | | $ | (0.73) | | | $ | 1.07 | |
| | | | | |
| | | | | |
| | | | | |
| Net income (loss) to common stockholders per share-diluted | $ | 4.31 | | | $ | (0.73) | | | $ | 1.04 | |
| | | | | |
| Anti-dilutive shares excluded related to: | | | | | |
| Outstanding stock options, restricted stock and restricted stock units | 40 | | | 1,026 | | | 30 | |
| Convertible debt | — | | | 930 | | | — | |
(1) Excludes the effects of the assumed issuance of common stock associated with the assumed exercise of outstanding stock options and potential shares of common stock issuable upon vesting of restricted stock and restricted stock units, and a conversion premium for the 2026 Convertible Notes, as the inclusion would be anti-dilutive, but they could become dilutive in the future.
23. SUPPLEMENTAL CASH FLOW INFORMATION
The following is supplemental cash flow information for the periods presented (in thousands):
| | | | | | | | | | | | | | | | | |
| Fiscal Years |
| 2026 | | 2025 | | 2024 |
| Cash paid for interest | $ | 5,020 | | | $ | 3,223 | | | $ | 3,985 | |
| Cash paid for income taxes | $ | 15,893 | | | $ | 16,192 | | | $ | 5,997 | |
| Non-cash activities: | | | | | |
| Issuance of common stock for settlement of convertible notes | $ | 283,650 | | | $ | — | | | $ | — | |
| Issuance of common stock for convertible debt exchange | $ | — | | | $ | 205,915 | | | $ | — | |
| Issuance of common stock in connection with the RF Business Acquisition | $ | — | | | $ | — | | | $ | 57,733 | |
| Non-cash capital expenditures | $ | 4,655 | | | $ | 2,222 | | | $ | 311 | |
| Purchase of software licenses and licensed technology included in liabilities | $ | 3,422 | | | $ | 17,078 | | | $ | 2,500 | |
Purchase of software licenses and licensed technology included in liabilities relates to commitments to purchase and pay for software and licensed technology over a two year period.
24. ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME
The components of accumulated other comprehensive (loss) income, net of income taxes, are as follows (in thousands):
| | | | | | | | | | | | | | | | | |
| Foreign Currency Items | | Other Items | | Total |
| Balance - September 27, 2024 | $ | 773 | | | $ | 1,732 | | | $ | 2,505 | |
| Foreign currency translation gain, net of tax | 1,682 | | | — | | | 1,682 | |
| | | | | |
| Unrealized gain on short-term investments, net of tax | — | | | 847 | | | 847 | |
| Balance - October 3, 2025 | 2,455 | | | 2,579 | | | 5,034 | |
| Foreign currency translation loss, net of tax | (297) | | | — | | | (297) | |
| | | | | |
| Unrealized loss on short-term investments, net of tax | — | | | (7,786) | | | (7,786) | |
| Balance - October 2, 2026 | $ | 2,158 | | | $ | (5,207) | | | $ | (3,049) | |
25. SEGMENT REPORTING, GEOGRAPHIC AND SIGNIFICANT CUSTOMER INFORMATION
We have one reportable operating segment that designs, develops, manufactures and markets semiconductors and modules. The determination of reportable operating segments is based on the chief operating decision maker’s (“CODM”) use of financial information provided for the purposes of assessing performance and making operating decisions. The Company’s CODM is its President and Chief Executive Officer and Chair of the Board. In evaluating financial performance and making operating decisions, the CODM primarily uses consolidated metrics. The Company assesses its determination of operating segments at least annually. We continue to evaluate our reporting structure and the potential impact of any changes on our segment reporting. The accounting policies of the single operating segment are the same as those described in the summary of significant accounting policies.
The CODM uses consolidated gross profit and net income (loss) to assess financial performance against prior periods and our competitors, to decide how to allocate resources and to evaluate income generated from segment assets in deciding whether to reinvest profits into our operations or into other parts of the entity, such as for acquisitions or other investments. The measure of segment assets is reported on the balance sheet as total assets. Financial forecasts and budget to actual results used by the CODM to assess performance and allocate resources, as well as those used for strategic decisions related to headcount and capital expenditures are also reviewed on a consolidated basis.
The following table presents a summary of consolidated net income (loss) inclusive of significant segment expenses and other expense information provided to the CODM (in thousands):
| | | | | | | | | | | | | | | | | |
| Fiscal Years |
| 2026 | | 2025 | | 2024 |
| Revenue | $ | 1,327,623 | | | $ | 967,258 | | | $ | 729,578 | |
| Less: | | | | | |
| Cost of revenue (1) | 537,529 | | | 411,969 | | | 306,942 | |
| Research and development (1) | 247,622 | | | 208,605 | | | 161,248 | |
| Selling, general and administrative (1) | 118,081 | | | 100,952 | | | 86,355 | |
| Share-based compensation including cash incentive stock units (2) | 99,690 | | | 86,139 | | | 50,191 | |
| Amortization expense (3) | 13,473 | | | 22,365 | | | 32,392 | |
| Acquisition and integration related costs | 5,761 | | | 7,576 | | | 18,784 | |
| Income from operations | 305,467 | | | 129,652 | | | 73,666 | |
| Interest income, net of interest expense | 23,430 | | | 24,337 | | | 17,850 | |
| Gain on investment fair value | 60,989 | | | — | | | — | |
| Loss on extinguishment of debt | — | | | (193,098) | | | — | |
| Gain on acquired assets and other income, net | — | | | 10,084 | | | 10 | |
| Income tax expense | 54,635 | | | 25,185 | | | 14,667 | |
| Net income (loss) | $ | 335,251 | | | $ | (54,210) | | | $ | 76,859 | |
(1) Excludes share-based compensation including cash incentive stock units, amortization expense and acquisition and integration related costs.
(2) Includes share-based compensation expense for awards that are equity and liability classified on our balance sheet and the related employer tax expense at vesting.
(3) Relates to acquired intangible assets and excludes amortization for purchased software licenses and licensed technology.
This expense information is based on management’s internal view of expense classification when reviewing aspects of financial and operating performance of the business, and may not be representative of expense classification that is comparable to other peer
companies’ internal management views. As a result, this expense information should not be considered in isolation or as substitute for analysis of MACOM’s results in conjunction with the accompanying consolidated financial statements and notes thereto.
Geographic and Significant Customer Information
For information regarding revenue by geographic regions, based upon customer locations, see Note 3 - Revenue.
Information regarding net property and equipment in different geographic regions is presented below (in thousands):
| | | | | | | | | | | |
| As of |
| October 2, 2026 | | October 3, 2025 |
| Net Property and Equipment by Geographic Region | |
| United States | $ | 184,035 | | | $ | 172,583 | |
| France | 46,156 | | | 40,686 | |
Other Countries (1) | 21,768 | | | 17,022 | |
| Total | $ | 251,959 | | | $ | 230,291 | |
(1) Other than the United States and France, no country or region represented greater than 10% of the total net property and equipment as of the dates presented.
Customer Concentration
The following is a summary of customer concentrations as a percentage of total sales and accounts receivable as of and for the periods presented:
| | | | | | | | | | | | | | | | | |
| Fiscal Years |
| Revenue | 2026 | | 2025 | | 2024 |
| Customer A | 20 | % | | 12 | % | | 11 | % |
| Customer B | 14 | % | | 11 | % | | — | |
| | | | | |
| | | | | |
| | | | | | | | | | | |
| October 2, 2026 | | October 3, 2025 |
| Accounts Receivable | |
| Customer A | 29 | % | | 11 | % |
| Customer B | 11 | % | | 11 | % |
| Customer C | — | | | 11 | % |
| | | |
| | | |
| | | |
No other customer represented more than 10% of revenue or accounts receivable in the periods presented in the accompanying Consolidated Financial Statements. In fiscal years 2026, 2025 and 2024, our top ten customers represented an aggregate of 58%, 57% and 56% of total revenue, respectively.